Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells
Shizuko Sei(Science Applications International Corporation (United States)), Joseph E. Tomaszewski(National Cancer Institute)
Cited by 118
Related Papers
Lynch syndrome cancer vaccines: A roadmap for the development of precision immunoprevention strategies
|Frontiers in Oncology|2023|30